Previous 10 | Next 10 |
2023-10-12 05:03:31 ET Summary Coloplast's shares have lagged behind other medical device companies on worries over margin pressure and aggressive moves to accelerate long-term growth. The company is expected to report organic revenue growth of around 8% for FQ4'23, but concerns r...
2023-10-11 11:03:36 ET More on Boston Scientific ADVENT Offers Up An Early Present For Boston Scientific Investors Boston Scientific Q2 2023 Earnings Call Transcript Boston Scientific Remains Operationally Sound But May Have Limited Upside Boston Scientific e...
Boston Scientific Announces Conference Call Discussing Third Quarter 2023 Results PR Newswire MARLBOROUGH, Mass. , Oct. 2, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results and business hi...
NORTHAMPTON, MA / ACCESSWIRE / September 27, 2023 / At Boston Scientific, we strive to advance science for life, which includes inspiring the next generation of STEM professionals who will help shape the future of health care. Using a combination of hands-on experiences and classroom education, ...
2023-09-26 09:59:28 ET More on Edwards Lifesciences Seeking Alpha’s Quant Rating on Edwards Lifesciences Historical earnings data for Edwards Lifesciences Financial information for Edwards Lifesciences Edwards Lifesciences: Rising Dominance In Str...
2023-09-21 16:49:56 ET More on Boston Scientific Boston Scientific Remains Operationally Sound But May Have Limited Upside Boston Scientific to acquire Relievant Medsystems Despite a slower Q2, Needham sees medtech market growing 7% in 2023 Boston Scientific ...
NORTHAMPTON, MA / ACCESSWIRE / September 21, 2023 / Boston Scientific As a leader in health care, Boston Scientific is dedicated to creating healthier communities in a wealth of ways, including large-scale programs like Close the Gap that help increase health equity in the U.S. and global c...
CVS Health appoints Michael F. Mahoney to its Board of Directors PR Newswire WOONSOCKET, R.I. , Sept. 21, 2023 /PRNewswire/ -- CVS Health Corporation (NYSE: CVS) has appointed Michael F. Mahoney , Chairman and CEO of Boston Scientific Corporation (NYSE: BSX),...
2023-09-20 06:04:00 ET More on market strategy SPY, QQQ, ARKK, Oil Conspire To Point To A High Return-High Risk Market (Technical Analysis) No Signs Of A Major Top Yet, Staying Long XYLD: The S&P 500 Is Begging You To Consider Covered Call ETFs, But JEPI Is Not T...
2023-09-19 07:28:44 ET More on Boston Scientific Seeking Alpha’s Quant Rating on Boston Scientific ADVENT Offers Up An Early Present For Boston Scientific Investors Boston Scientific Remains Operationally Sound But May Have Limited Upside For further d...
News, Short Squeeze, Breakout and More Instantly...
Boston Scientific Corporation Company Name:
BSX Stock Symbol:
NYSE Market:
Boston Scientific Corporation Website:
Alkermes plc (ALKS) is expected to report $0.64 for Q2 2024 Acerinox ADR (ANIOY) is expected to report for Q2 2024 Allegion plc (ALLE) is expected to report $1.77 for Q2 2024 Deutsche Bank AG (DB) is expected to report $0.43 for Q2 2024 Pathward Financial Inc. (CASH) is expected t...
Boston Scientific Announces Results for Second Quarter 2024 PR Newswire MARLBOROUGH, Mass. , July 24, 2024 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $4.120 billion during the second quarter of 2024, growing 14.5 percent ...
Shares of Boston Scientific Corporation (NYSE: BSX) traded at a new 52-week high today and are currently trading at $78.31. So far today, approximately 1.5M shares have been exchanged, as compared to an average 30-day volume of 5.37M shares. Boston Scientific Corporation develops, manufacture...